Study to Evaluate the Impact of the “PROactive Telecoaching Program” on Physical Activity in Patients With COPD.
- Added on March 10, 2014
Sponsor: Novartis Pharmaceuticals
Collaborators: Innovative Medicines Initiative (PROactive Project), Innovative Medicines Initiative.
Information provided by (Responsible Party): Novartis (Novartis Pharmaceuticals)
Clinicaltrials.gov Identifier: NCT01992081
Purpose: This study will test two instruments to measure physical activity in COPD patients: A questionnaire and two small physical activity monitors .Patients will be randomized to either receive the telecoaching program in addition to usual care or only the usual care. Study will include around 510 patients in 5 countries in Europe.